Energy and Appetite Regulation by High and Low CHO Diets
Project Number5R21AT002753-02
Contact PI/Project LeaderSTADLER, DIANE D
Awardee OrganizationOREGON HEALTH & SCIENCE UNIVERSITY
Description
Abstract Text
DESCRIPTION (provided by applicant): The rising epidemic of obesity in the United States is accompanied by widespread public use of low carbohydrate diets for weight loss. The popularity of these diets is due partly to the promise of a "metabolic advantage" that promotes faster weight loss without an overriding sense of hunger. If this claim is true, we hypothesize that a low-carbohydrate diet will impact hormones and other factors that regulate appetite and energy balance, and result in lower energy intake and greater weight loss, than a high complex carbohydrate diet. To test this hypothesis, we will conduct a randomized, controlled feeding trial in which obese adults will be randomly assigned to one of three interventions: a low-carbohydrate-ad libitum diet, a high-carbohydrate -ad libitum diet, or a high-carbohydrate-energy-restricted diet. The low-carbohydrate diet will be modeled after the Induction Phase of the Atkins Diet. The high carbohydrate diet will be based on the "Dietary Approaches to Stop Hypertension (DASH)" diet. Participants will eat a standardized weight maintenance diet for 3 weeks. Then, for 6-weeks, participants assigned to either ad libitum group will be given their assigned diet at 120% of there estimated energy needs to maintain weight and allowed to eat as much as desired. Participants assigned to the energy-restricted group will be provided a DASH diet at 67% of their estimated energy needs to maintain weight and asked to eat all foods provided. Food intake will be measured daily. Body weight and hunger and satiety scores will be measured three times a week. Body composition and energy expenditure will be measured before and after the intervention. 24-hour profiles of hormones and other factors that influence central appetite and weight regulation (insulin, leptin, ghrelin, PYY, GLP-1) will be measured before, and on first and last days of the intervention, to compare acute and chronic metabolic effects of the diets. The analysis of primary outcomes will be based on repeated measures and longitudinal models methodology. This study offers a unique opportunity to explore how extreme differences in dietary composition, before and after weight loss, affect components of energy balance and markers of central appetite and weight regulation. These results will be used to design hypothesis-driven studies of the identified mediators of appetite and weight regulation in response to dietary manipulation.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
appetitebioenergeticsblood chemistrybody compositionbody weightclinical researchclinical trialsdietary carbohydratesghrelinhuman subjecthungerincretin hormoneinsulinleptinneuropeptide Ynutrient intake activitynutrition related tagobesitypatient oriented researchquestionnairessatiationsurinalysisweight control
National Center for Complementary and Integrative Health
CFDA Code
213
DUNS Number
096997515
UEI
NPSNT86JKN51
Project Start Date
30-September-2005
Project End Date
31-August-2009
Budget Start Date
01-September-2006
Budget End Date
31-August-2009
Project Funding Information for 2006
Total Funding
$275,040
Direct Costs
$195,300
Indirect Costs
$79,740
Year
Funding IC
FY Total Cost by IC
2006
National Center for Complementary and Integrative Health
$275,040
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R21AT002753-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R21AT002753-02
Patents
No Patents information available for 5R21AT002753-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R21AT002753-02
Clinical Studies
No Clinical Studies information available for 5R21AT002753-02
News and More
Related News Releases
No news release information available for 5R21AT002753-02
History
No Historical information available for 5R21AT002753-02
Similar Projects
No Similar Projects information available for 5R21AT002753-02